Yang Rong, Xu Linfeng, Lian Huibo, Gan Weidong, Guo Hongqian
Department of Urology, The Affiliated Drum Tower Hospital of Nanjing University , School of Medicine, Nanjing, Jiangsu, China .
J Endourol. 2014 Oct;28(10):1208-14. doi: 10.1089/end.2013.0635. Epub 2014 Aug 6.
To analyze the feasibility, safety, and therapeutic effects of retroperitoneoscopic-guided cool-tip radiofrequency ablation (RCRFA) used for the treatment of adrenocortical aldosteronoma.
We performed a retrospective comparison of RCRFA (n=12) and laparoscopic partial adrenalectomy (LPA) (n=26) in the patients with solitary aldosterone-producing adenoma in our center from 2006 to 2009. Intraoperative and follow-up data were reviewed for clinical parameters and hormone levels. Univariate analysis was performed to measure the consistency of these clinical parameters preoperatively and postoperatively.
All patients presented hypertension, hypokalemia, and high aldosterone/renin ratio (ARR>30) preoperatively and were finally histologically confirmed as aldosteronoma. Technical success rate of these two procedures was 100%. Every patient was followed up for more than 3 years (mean 49.2±15.6 months). There was no evidence of residual or recurrent lesion postoperatively. ARR declined significantly postoperatively compared with preoperatively (54.33±24.90 vs 5.50±3.30 in the RCRFA group and 51.45±29.12 vs 6.67±3.75 in the LPA group, p<0.05). Hypokalemia was resolved in all patients after the surgery. A majority of patients (91.7% in the RCRFA group and 96.2% in the LPA group) were cured without any further need of antihypertensive medication or experienced an improvement in hypertension. Antihypertensive medications reduced significantly after surgical procedures. RCRFA and LPA demonstrated similar therapeutic effects. Compared with LPA, RCRFA provided a shorter operative time (65.6±13.5 minutes vs 86.0±16.5 minutes in LPA, p<0.05), less blood loss (20.0±11.3 mL vs 60.8±52.0 mL in LPA, p<0.05), and lower complication rate (16.7% vs 26.9% in LPA).
RCRFA might be an alternative for LPA in selected patients with adrenocortical aldosteronoma. Due to limited sample size, more experience is necessary to validate this procedure.
分析后腹腔镜引导下冷循环射频消融术(RCRFA)治疗肾上腺皮质醛固酮瘤的可行性、安全性及治疗效果。
对2006年至2009年在本中心接受治疗的孤立性醛固酮分泌腺瘤患者进行回顾性比较,其中RCRFA组12例,腹腔镜肾上腺部分切除术(LPA)组26例。回顾术中及随访数据,观察临床参数和激素水平。进行单因素分析以评估术前和术后这些临床参数的一致性。
所有患者术前均有高血压、低钾血症及高醛固酮/肾素比值(ARR>30),最终经组织学确诊为醛固酮瘤。两种手术的技术成功率均为100%。所有患者均随访超过3年(平均49.2±15.6个月)。术后无残留或复发病变迹象。与术前相比,术后ARR显著下降(RCRFA组:54.33±24.90 vs 5.50±3.30;LPA组:51.45±29.12 vs 6.67±3.75,p<0.05)。术后所有患者低钾血症均得到纠正。大多数患者(RCRFA组91.7%,LPA组96.2%)治愈,无需进一步服用降压药物或高血压病情改善。手术后降压药物用量显著减少。RCRFA和LPA显示出相似的治疗效果。与LPA相比,RCRFA手术时间更短(65.6±13.5分钟 vs LPA组的86.±16.5分钟,p<0.05),出血量更少(20.0±11.3 mL vs LPA组的60.8±52.0 mL,p<0.05),并发症发生率更低(16.7% vs LPA组的26.9%)。
对于部分肾上腺皮质醛固酮瘤患者,RCRFA可能是LPA的替代方案。由于样本量有限,需要更多经验来验证该手术。